Skip to content

Voyager I: Patient Discharge Using the AB5000 Portable Driver System

Voyager I: Patient Discharge Using the AB5000 Portable Driver System

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00971776
Enrollment
9
Registered
2009-09-04
Start date
2008-06-30
Completion date
2013-09-30
Last updated
2013-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Cardiac Dysfunction

Keywords

Patient receiving AB5000 ventricle potentially recoverable

Brief summary

The AB Portable Driver System will allow patients supported with the Circulatory Support System to be discharged home when their medical condition improves to an ambulating status and will continue to receive the assistance of the AB 5000 ventricle for their heart recovery.

Interventions

DEVICEAB Portable Driver System

Evaluate the safety and performance of the AB Portable Driver System in home environment.

Sponsors

Abiomed Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The subject is an AB5000 Circulatory Support System patient (in accordance FDA-approved indications for use) who is suffering acute cardiac dysfunction and is potentially recoverable; * The subject is male or female, age 18 years or older; * The subject is able to ambulate unassisted; * The subject is on stable oral anticoagulation over 7 days (INR 2-4) with no active bleeding; * The subject is willing and able to read, understand and sign the study specific informed consent form; * The subject agrees to comply with study protocol requirements, including all follow-up visits and completion of Qol and NIH stroke scale assessments.

Exclusion criteria

* The subject, pre-device implant, is qualified as a transplant candidate. * There is an absence of a trained companion. * There is an absence of a psycho-social support. * The subject has an inadequate home environment, such as poor access which may hinder movements. * The subject has experienced hypotension in last 24 hours based on two consecutive readings spaced by 8 hours with systolic blood pressures \< 90 mmHg. * The subject requires respiratory assistance. * The subject has an active infection (positive blood culture and/or body T ≥ 38 degrees C, and/or WBC ≥ 12K/µL). * The subject requires tube feeding. * The subject has any other medical condition requiring hospitalization.

Design outcomes

Primary

MeasureTime frame
Adverse events, Quality of life assessment, NIH Stroke Scale Assessments, and patient outcome after readmissionPre-discharge, 30 days post-discharge, 90 days or re-admission

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026